Royal Philips: Late-breaking data at ACC.22 with over 1 mill

Royal Philips: Late-breaking data at ACC.22 with over 1 million patients demonstrates a major gap in guideline adherence resulting in higher mortality for patients with infected CIEDs

April 4, 2022 Largest ever real-world analysis of Cardiac Implantable Electronic Device (CIED) infection treatment presented at the American College of Cardiology's 71st Annual Scientific Session

Related Keywords

United States , Netherlands , Washington , Amsterdam , Noord Holland , American , Coll Cardiol , Philipsby Sean Pokorney , Jonathanp Piccini , Clin Electrophysiol , Chris Landon , Founder Of Arrhythmia Alliance , European Heart Rhythm Association , American Heart Association , American College Of Cardiology , Duke Clinical Research Institute , Philips , Duke Heart Center , Philips Global Press Office , Duke University , Cardiac Implantable Electronic Device , American College , Annual Scientific Session , Medicare Study , Lead Management , Assistant Professor , Duke University School , Duke Clinical Research , Cardiac Electrophysiology , Duke Heart , Trudie Lobban , Arrhythmia Alliance , Senior Vice President , General Manager Image Guided Therapy Devices , Late Breaking Clinical , United States April , Consensus Statement , Heart Rhythm , Internal Medicine , Contemporary Setting , Multicenter Observational Retrospectivestudy , Consecutive Laser Lead Extractions , Royal , Gate , Breaking , Data , Dover , Billion , Patients , Emonstrates , Major , Guideline , Adherence , Resulting , Higher , Ortality , Infected , Ieds ,